Home/Windward Bio/Claudia D'Augusta, PhD

CD

Claudia D'Augusta, PhD

Chief Financial Officer

Therapeutic Areas

Immunology Respiratory Dermatology

Windward Bio Pipeline

Drug	Indication	Phase
WIN378	Asthma (and potential COPD)	Phase 2
WIN027	Immunological diseases (e.g., Asthma, Atopic Dermatitis)	Clinical-stage (Phase not specified)

Leadership Team at Windward Bio

Luca Santarelli, MD

Founder, Chief Executive Officer, and Board Chair

Omar Khwaja, MD, PhD

Chief Medical Officer

Chief Operating Officer

Scott Applebaum

Chief Legal and Business Officer

Michael Steininger, MSc

Head of Human Resources

Martine Mazzetti, PhD

View full Windward Bio profile